Castlight Health, inc. (NYSE:CSLT) was upgraded by stock analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a report released on Wednesday.
Several other brokerages have also weighed in on CSLT. Cowen and Company reaffirmed a “market perform” rating and issued a $4.50 target price (up from $4.00) on shares of Castlight Health, inc. in a research report on Thursday, August 3rd. ValuEngine raised Castlight Health, inc. from a “sell” rating to a “hold” rating in a research report on Tuesday, August 1st. Zacks Investment Research raised Castlight Health, inc. from a “sell” rating to a “hold” rating in a research report on Tuesday, June 27th. Dougherty & Co reaffirmed a “buy” rating on shares of Castlight Health, inc. in a research report on Thursday, August 17th. Finally, Chardan Capital began coverage on Castlight Health, inc. in a research report on Tuesday, June 6th. They issued a “buy” rating and a $4.50 target price on the stock. Three research analysts have rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $4.57.
Shares of Castlight Health, inc. (CSLT) opened at 4.12 on Wednesday. Castlight Health, inc. has a 1-year low of $3.05 and a 1-year high of $5.50. The firm’s market cap is $543.21 million. The firm’s 50-day moving average price is $4.00 and its 200 day moving average price is $3.88.
Castlight Health, inc. (NYSE:CSLT) last issued its earnings results on Wednesday, August 2nd. The software maker reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.02. The business had revenue of $32.10 million for the quarter, compared to analyst estimates of $31.14 million. Castlight Health, inc. had a negative return on equity of 36.30% and a negative net margin of 42.54%. The business’s quarterly revenue was up 36.0% on a year-over-year basis. During the same period last year, the company posted ($0.11) EPS. On average, equities research analysts forecast that Castlight Health, inc. will post ($0.25) EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “BidaskClub Upgrades Castlight Health, inc. (CSLT) to Sell” was first published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this story on another website, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this story can be viewed at https://www.chaffeybreeze.com/2017/09/15/bidaskclub-upgrades-castlight-health-inc-cslt-to-sell.html.
In related news, insider Giovanni M. Colella sold 23,000 shares of the stock in a transaction on Wednesday, August 9th. The stock was sold at an average price of $4.06, for a total value of $93,380.00. Following the completion of the sale, the insider now directly owns 78,906 shares in the company, valued at approximately $320,358.36. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Giovanni M. Colella sold 26,800 shares of the stock in a transaction on Friday, August 11th. The shares were sold at an average price of $3.89, for a total value of $104,252.00. Following the completion of the sale, the insider now owns 78,906 shares of the company’s stock, valued at $306,944.34. The disclosure for this sale can be found here. Over the last quarter, insiders sold 208,287 shares of company stock valued at $795,240. 37.43% of the stock is owned by insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in CSLT. FMR LLC increased its holdings in Castlight Health, inc. by 49.2% in the 2nd quarter. FMR LLC now owns 11,433,928 shares of the software maker’s stock valued at $47,451,000 after purchasing an additional 3,768,009 shares in the last quarter. General Electric Co. acquired a new stake in Castlight Health, inc. in the 2nd quarter valued at $4,338,000. Vanguard Group Inc. increased its holdings in Castlight Health, inc. by 36.0% in the 2nd quarter. Vanguard Group Inc. now owns 3,636,948 shares of the software maker’s stock valued at $15,094,000 after purchasing an additional 963,188 shares in the last quarter. GMT Capital Corp acquired a new stake in Castlight Health, inc. in the 1st quarter valued at $2,568,000. Finally, Granite Investment Partners LLC acquired a new stake in Castlight Health, inc. in the 2nd quarter valued at $1,613,000. Hedge funds and other institutional investors own 41.30% of the company’s stock.
Castlight Health, inc. Company Profile
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with MarketBeat.com's FREE daily email newsletter.